Effect of aerobic exercise training on asthma control in postmenopausal women (the ATOM-study): protocol for an outcome assessor, randomised controlled trial.
asthma
chronic airways disease
immunology
sports medicine
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
22 04 2021
22 04 2021
Historique:
entrez:
23
4
2021
pubmed:
24
4
2021
medline:
21
5
2021
Statut:
epublish
Résumé
Late-onset asthma in postmenopausal women is characterised by poor disease control with daily symptoms and reduced quality of life despite treatment with inhaled antiasthma therapies. These patients represent a phenotype that is characterised by low eosinophilic airway inflammation, severe symptoms, moderate obesity and poor response to inhaled antiasthma therapies, which highlights the need of identification of alternative treatment strategies. Thus, this study aims to evaluate if regular high-intensity aerobic exercise improves symptom control in postmenopausal women with asthma. This is an ongoing randomised controlled trial planning to enrol 40 postmenopausal women with late-onset asthma. Participants are randomised 1:1 either to supervised exercise training (spinning) three times per week for 12 weeks or to usual care. The primary outcome is change from baseline to follow-up in the Asthma Control Questionnaire. Secondary outcomes are changes in markers of systemic inflammation, airway inflammation, body composition and right ventricular function of the heart. The study is approved by the Ethics Committee in the Capital Region of Denmark nr. H-18028966 and the Danish Data Protection Agency nr. VD-2019-59. The methods used in the study are well known and have a low risk with a chance of substantial improvement in disease control in this patient group. Results are planned to be published in an international peer-reviewed medical journal regardless of outcome. NCT03747211.
Identifiants
pubmed: 33888532
pii: bmjopen-2021-049477
doi: 10.1136/bmjopen-2021-049477
pmc: PMC8070869
doi:
Banques de données
ClinicalTrials.gov
['NCT03747211']
Types de publication
Clinical Trial Protocol
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e049477Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Drugs Aging. 2017 Mar;34(3):157-162
pubmed: 28164255
Am J Respir Crit Care Med. 2007 Jan 15;175(2):126-35
pubmed: 17095746
World Allergy Organ J. 2017 Dec 27;10(1):46
pubmed: 29308113
Respir Med. 2014 Dec;108(12):1723-32
pubmed: 25456708
J Asthma. 2014 Mar;51(2):113-8
pubmed: 24102534
Sao Paulo Med J. 2017 Jan-Feb;135(1):4-14
pubmed: 28076614
J Allergy Clin Immunol. 2017 Jun;139(6):1797-1807
pubmed: 27773852
Curr Allergy Asthma Rep. 2017 Mar;17(3):19
pubmed: 28332107
J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):803-811
pubmed: 29133220
Eur Respir J. 2016 Oct;48(4):1052-1062
pubmed: 27540019
Respir Med. 2005 May;99(5):553-8
pubmed: 15823451
Chest. 1987 Nov;92(5):789-95
pubmed: 3665592
Am J Physiol Lung Cell Mol Physiol. 2010 Apr;298(4):L521-30
pubmed: 20097735
Front Immunol. 2015 Nov 16;6:568
pubmed: 26635789
Am J Respir Crit Care Med. 2008 Aug 1;178(3):218-224
pubmed: 18480428
Eur Respir J. 2020 Jul 30;56(1):
pubmed: 32350100
Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1849-54
pubmed: 11734435
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Monaldi Arch Chest Dis. 2007 Sep;67(3):135-41
pubmed: 18018752
Allergy. 2013;68(5):674-80
pubmed: 23590217
J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):967-978.e3
pubmed: 28389304
Circulation. 2016 Jun 14;133(24):e694-711
pubmed: 27143685
Respir Med. 2016 Aug;117:223-9
pubmed: 27492535